Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutation analysis of the MCM gene in Korean patients with MMA.
|
15781199 |
2005 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Methylmalonic acidemia (MMA) is a typical type of organic acidemia caused by defects in methylmalonyl-CoA mutase or adenosyl-cobalamin synthesis.
|
30564975 |
2019 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Methylmalonic acidemia (MMA) can be caused by mutations in the gene coding for the methylmalonyl CoA mutase (MCM) apoenzyme or by mutations in genes required for provision of its adenosylcobalamin cofactor.
|
1968706 |
1990 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
We report three patients with isolated MUT related MMA who presented with severe refractory pancytopenia during acute illness.
|
29330964 |
2018 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the MUT locus encoding for the methylmalonyl-CoA mutase (MCM) apoenzyme are responsible for the mut forms of methylmalonic acidemia (MMA).
|
11528502 |
2001 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Four different forms of isolated MMA have been described: mut MMA associated with defects in the MCM apoenzyme, and phenotypically divided into two subtypes mut- and mut0 MMA, and three different defects involved in the synthesis of the active form of the cofactor adenosylcobalamin, termed cbl MMA, and classified into three different complementation groups cblA, cblB, and cblH associated with defects in the MMAA and MMAB genes and with an unidentified protein, respectively.
|
15781192 |
2005 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
We analyzed a cohort of 40 MCM-deficient patients with MMA affected by either the mut(o) or the mut- form of the disease.
|
15643616 |
2005 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Pre-clinical efficacy and dosing of an AAV8 vector expressing human methylmalonyl-CoA mutase in a murine model of methylmalonic acidemia (MMA).
|
23046887 |
2012 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Genetic and biochemical prenatal diagnosis was performed at 11 weeks of gestation in a family with a proband affected by mut methylmalonic aciduria (MMA) and homozygotes for the MUT gene c.643G>A (p.Gly215Ser) mutation.
|
16451139 |
2006 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Methylmalonic acidemia (MMA) is caused by the deficient activity of l-methylmalonyl-CoA mutase, which is a vitamin B(12) (or cobalamin, Cbl)-dependent enzyme.
|
15308131 |
2004 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Genetic defects in the methylmalonyl-CoA mutase (MCM) gene cause methylmalonic acidemia (MMA).
|
9929975 |
1999 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The mut methylmalonic acidemia (MMA) caused by the deficiency of methylmalonyl-CoA mutase (MCM) activity, which results from defects in the MUT gene.
|
31466887 |
2019 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The existence of human methylmalonic acidemia (MMA) due to the presence of mutations in MCM shows the importance of its role in metabolism.
|
22661206 |
2012 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In order to accurately model the human MMA disorder we introduced this mutation onto the human methylmalonyl-CoA mutase locus of a bacterial artificial chromosome.
|
23024777 |
2012 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Methylmalonic aciduria (MMA) is a disorder of organic acid metabolism resulting from a functional defect of methylmalonyl-CoA mutase (MCM).
|
22792386 |
2012 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Isolated methylmalonic acidemia (MMA) is a genetically heterogeneous organic acid disorder caused by either deficiency of the enzyme methylmalonyl-CoA mutase (MCM), or a defect in the biosynthesis of its cofactor, adenosyl-cobalamin (AdoCbl).
|
22695176 |
2012 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the MUT gene, which encodes the mitochondrial enzyme methylmalonyl-CoA mutase, are responsible for the mut form of methylmalonic aciduria (MMA).
|
27233228 |
2016 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Western blot analysis revealed reduced MUT protein for all 34 cell lines (27 mut(0) , seven mut(-) ) tested, suggesting protein instability as a major mechanism of deficiency in mut-type MMA.
|
27167370 |
2016 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Methylmalonic acidemia (MMA) is an autosomal recessive inherited disorder caused by complete or partial deficiency of the enzyme methylmalonyl-CoA mutase (mut0 enzymatic subtype or mut- enzymatic subtype, respectively); a defect in the transport or synthesis of its cofactor, adenosyl-cobalamin (cblA, cblB, or cblD-MMA); or deficiency of the enzyme methylmalonyl-CoA epimerase.
|
29996803 |
2018 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
TAT-MTS-MCM fusion proteins reduce MMA levels and improve mitochondrial activity and liver function in MCM-deficient cells.
|
29265583 |
2018 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The results show that propionate metabolism and methylmalonyl-CoA mutase (MCM) activity are intact in primary T cells, EBV-B cells, and CD34+ haematopoietic stem cell-derived granulocytes, whereas they are defective in those from a mut MMA child.
|
10518277 |
1999 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We report this novel mutation, including its clinical and biochemical features and genetic defects, in the MUT gene of three patients affected with isolated MMA.
|
26449400 |
2016 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Methylmalonic acidaemia (MMA) is a genetic disorder caused by defects in methylmalonyl-CoA mutase or in any of the different proteins involved in the synthesis of adenosylcobalamin.
|
17957493 |
2008 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutase-deficient (MUT) methylmalonic aciduria (MMA) is an autosomal recessive inborn error of organic acid metabolism, resulting from a functional defect in the nuclear encoded mitochondrial enzyme methylmalonyl-CoA mutase (MCM) (EC.5.4.99.2).
|
12402345 |
2002 |
Mastitis-metritis-agalactia syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Methylmalonic acidemia (MMA) is a common organic acidemia, mainly due to methylmalonyl-CoA mutase (MCM) or its coenzyme cobalamin (VitB12) metabolic disorders.
|
29068997 |
2017 |